Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation

NACompletedINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

September 20, 2019

Primary Completion Date

December 30, 2021

Study Completion Date

December 31, 2021

Conditions
Allergy
Interventions
DIAGNOSTIC_TEST

Skin Testing

Percutaneous skin prick followed by Intradermal Injections of NMBAs at increasing concentrations compared with an established positive and negative control.

Trial Locations (1)

32224

Mayo Clinic, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04046731 - Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation | Biotech Hunter | Biotech Hunter